It may still have an effect in time to recovery, which is important, both in reducing suffering and helping hospital capacity. Of course that has to be weighed

It may still have an effect in time to recovery, which is important, both in reducing suffering and helping hospital capacity. Of course that has to be weighed against the side effects. In any event, I do not think that the $3K per treatment price is justified. By the way, there is a supplement that is far far cheaper than remdesivir and is available over the counter which has also shown to reduce time to recovery by about as much as remdesivir. See: https://investors.chromadex.com/news/news-details/2020/ChromaDex-Announces-Study-Results-Showing-Nutritional-Protocol-Including-Nicotinamide-Riboside-Plus-Standard-of-Care-Reduces-Recovery-Time-in-COVID-19-Patients-by-Nearly-30/default.aspx https://investors.chromadex.com/news/news-details/2020/Chrom... This is a 100 person trial, which is much less than the remdisivir trials, but still statistically significant. In any event, the risk is much lower, according to the study "adverse events were uncommon, benign, and self-limiting." The supplement is sold as truniagen.